カテゴリー： LP Information, 世界, 医療/バイオ

世界の抗片頭痛薬市場予測 2021年-2026年

【英語タイトル】Global Anti-Migraine Drugs Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9422）・商品コード：LPI21MY9422
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：166
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「抗片頭痛薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、トリプタン、麦角、その他など、用途別には、女性、男性などにセグメント区分してまとめました。抗片頭痛薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・抗片頭痛薬の世界市場概要（サマリー）
・抗片頭痛薬の企業別販売量・売上
・抗片頭痛薬の企業別市場シェア
・抗片頭痛薬の世界市場規模 2016年-2021年：種類別（トリプタン、麦角、その他）
・抗片頭痛薬の世界市場規模 2016年-2021年：用途別（女性、男性）
・抗片頭痛薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・抗片頭痛薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・抗片頭痛薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・抗片頭痛薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・抗片頭痛薬市場の成長要因・課題・動向
・抗片頭痛薬の世界市場予測 2021年-2026年
・抗片頭痛薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・抗片頭痛薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・抗片頭痛薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・抗片頭痛薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・抗片頭痛薬の世界市場予測：種類別（トリプタン、麦角、その他）
・抗片頭痛薬の世界市場予測：用途別（女性、男性）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Anti-Migraine Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Migraine Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti-Migraine Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Migraine Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Triptans
Ergots
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Women
Men

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Eli Lilly
Abbott Laboratories
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Amgen

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Migraine Drugs Consumption 2016-2026
2.1.2 Anti-Migraine Drugs Consumption CAGR by Region
2.2 Anti-Migraine Drugs Segment by Type
2.2.1 Triptans
2.2.2 Ergots
2.2.3 Others
2.3 Anti-Migraine Drugs Sales by Type
2.3.1 Global Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Anti-Migraine Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Anti-Migraine Drugs Sale Price by Type (2016-2021)
2.4 Anti-Migraine Drugs Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Anti-Migraine Drugs Sales by Application
2.5.1 Global Anti-Migraine Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Anti-Migraine Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Anti-Migraine Drugs Sale Price by Application (2016-2021)

3 Global Anti-Migraine Drugs by Company
3.1 Global Anti-Migraine Drugs Sales Market Share by Company
3.1.1 Global Anti-Migraine Drugs Sales by Company (2019-2021)
3.1.2 Global Anti-Migraine Drugs Sales Market Share by Company (2019-2021)
3.2 Global Anti-Migraine Drugs Revenue Market Share by Company
3.2.1 Global Anti-Migraine Drugs Revenue by Company (2019-2021)
3.2.2 Global Anti-Migraine Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Anti-Migraine Drugs Sale Price by Company
3.4 Global Manufacturers Anti-Migraine Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Migraine Drugs Product Location Distribution
3.4.2 Players Anti-Migraine Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Anti-Migraine Drugs by Region
4.1 Global Anti-Migraine Drugs by Region
4.1.1 Global Anti-Migraine Drugs Sales by Region
4.1.2 Global Anti-Migraine Drugs Revenue by Region
4.2 Americas Anti-Migraine Drugs Sales Growth
4.3 APAC Anti-Migraine Drugs Sales Growth
4.4 Europe Anti-Migraine Drugs Sales Growth
4.5 Middle East & Africa Anti-Migraine Drugs Sales Growth

5 Americas
5.1 Americas Anti-Migraine Drugs Sales by Country
5.1.1 Americas Anti-Migraine Drugs Sales by Country (2016-2021)
5.1.2 Americas Anti-Migraine Drugs Revenue by Country (2016-2021)
5.2 Americas Anti-Migraine Drugs Sales by Type
5.3 Americas Anti-Migraine Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Anti-Migraine Drugs Sales by Region
6.1.1 APAC Anti-Migraine Drugs Sales by Region (2016-2021)
6.1.2 APAC Anti-Migraine Drugs Revenue by Region (2016-2021)
6.2 APAC Anti-Migraine Drugs Sales by Type
6.3 APAC Anti-Migraine Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Anti-Migraine Drugs by Country
7.1.1 Europe Anti-Migraine Drugs Sales by Country (2016-2021)
7.1.2 Europe Anti-Migraine Drugs Revenue by Country (2016-2021)
7.2 Europe Anti-Migraine Drugs Sales by Type
7.3 Europe Anti-Migraine Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Anti-Migraine Drugs by Country
8.1.1 Middle East & Africa Anti-Migraine Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Anti-Migraine Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Anti-Migraine Drugs Sales by Type
8.3 Middle East & Africa Anti-Migraine Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anti-Migraine Drugs Distributors
10.3 Anti-Migraine Drugs Customer

11 Global Anti-Migraine Drugs Market Forecast
11.1 Global Anti-Migraine Drugs Forecast by Region
11.1.1 Global Anti-Migraine Drugs Forecast by Regions (2021-2026)
11.2.2 Global Anti-Migraine Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Anti-Migraine Drugs Forecast by Type
11.7 Global Anti-Migraine Drugs Forecast by Application

12 Key Players Analysis
12.1 Eli Lilly
12.1.1 Eli Lilly Eli Lilly Company Information
12.1.2 Eli Lilly Anti-Migraine Drugs Product Offered
12.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Eli Lilly Main Business Overview
12.1.5 Eli Lilly Latest Developments
12.2 Abbott Laboratories
12.2.1 Abbott Laboratories Company Information
12.2.2 Abbott Laboratories Anti-Migraine Drugs Product Offered
12.2.3 Abbott Laboratories Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Abbott Laboratories Main Business Overview
12.2.5 Abbott Laboratories Latest Developments
12.3 Eisai
12.3.1 Eisai Company Information
12.3.2 Eisai Anti-Migraine Drugs Product Offered
12.3.3 Eisai Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Eisai Main Business Overview
12.3.5 Eisai Latest Developments
12.4 Allergan
12.4.1 Allergan Company Information
12.4.2 Allergan Anti-Migraine Drugs Product Offered
12.4.3 Allergan Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Allergan Main Business Overview
12.4.5 Allergan Latest Developments
12.5 Endo
12.5.1 Endo Company Information
12.5.2 Endo Anti-Migraine Drugs Product Offered
12.5.3 Endo Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Endo Main Business Overview
12.5.5 Endo Latest Developments
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Information
12.6.2 GlaxoSmithKline Anti-Migraine Drugs Product Offered
12.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 GlaxoSmithKline Main Business Overview
12.6.5 GlaxoSmithKline Latest Developments
12.7 Impax Laboratories
12.7.1 Impax Laboratories Company Information
12.7.2 Impax Laboratories Anti-Migraine Drugs Product Offered
12.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Impax Laboratories Main Business Overview
12.7.5 Impax Laboratories Latest Developments
12.8 Pfizer
12.8.1 Pfizer Company Information
12.8.2 Pfizer Anti-Migraine Drugs Product Offered
12.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Pfizer Main Business Overview
12.8.5 Pfizer Latest Developments
12.9 AstraZeneca
12.9.1 AstraZeneca Company Information
12.9.2 AstraZeneca Anti-Migraine Drugs Product Offered
12.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 AstraZeneca Main Business Overview
12.9.5 AstraZeneca Latest Developments
12.10 Bayer
12.10.1 Bayer Company Information
12.10.2 Bayer Anti-Migraine Drugs Product Offered
12.10.3 Bayer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Bayer Main Business Overview
12.10.5 Bayer Latest Developments
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Company Information
12.11.2 Johnson & Johnson Anti-Migraine Drugs Product Offered
12.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Johnson & Johnson Main Business Overview
12.11.5 Johnson & Johnson Latest Developments
12.12 Merck
12.12.1 Merck Company Information
12.12.2 Merck Anti-Migraine Drugs Product Offered
12.12.3 Merck Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Merck Main Business Overview
12.12.5 Merck Latest Developments
12.13 Teva
12.13.1 Teva Company Information
12.13.2 Teva Anti-Migraine Drugs Product Offered
12.13.3 Teva Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Teva Main Business Overview
12.13.5 Teva Latest Developments
12.14 Amgen
12.14.1 Amgen Company Information
12.14.2 Amgen Anti-Migraine Drugs Product Offered
12.14.3 Amgen Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Amgen Main Business Overview
12.14.5 Amgen Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Anti-Migraine Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Triptans
Table 3. Major Players of Ergots
Table 4. Major Players of Others
Table 5. Global Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 6. Global Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 7. Global Anti-Migraine Drugs Revenue by Type (2016-2021) & ($ million)
Table 8. Global Anti-Migraine Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Anti-Migraine Drugs Sale Price by Type (2016-2021)
Table 10. Global Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 11. Global Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Anti-Migraine Drugs Value by Application (2016-2021)
Table 13. Global Anti-Migraine Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Anti-Migraine Drugs Sale Price by Application (2016-2021)
Table 15. Global Anti-Migraine Drugs Sales by Company (2019-2021) & (K Units)
Table 16. Global Anti-Migraine Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Anti-Migraine Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Anti-Migraine Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Anti-Migraine Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Anti-Migraine Drugs Producing Area Distribution and Sales Area
Table 21. Players Anti-Migraine Drugs Products Offered
Table 22. Anti-Migraine Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Anti-Migraine Drugs Sales by Region (2016-2021) (K Units)
Table 26. Global Anti-Migraine Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Anti-Migraine Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Anti-Migraine Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Anti-Migraine Drugs Sales by Country (2016-2021) & (K Units)
Table 30. Americas Anti-Migraine Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Anti-Migraine Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Anti-Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 34. Americas Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 35. Americas Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 36. Americas Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Anti-Migraine Drugs Sales by Region (2016-2021) & (K Units)
Table 38. APAC Anti-Migraine Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Anti-Migraine Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Anti-Migraine Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 42. APAC Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 43. APAC Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 44. APAC Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Anti-Migraine Drugs Sales by Country (2016-2021) & (K Units)
Table 46. Europe Anti-Migraine Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Anti-Migraine Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Anti-Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 50. Europe Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 51. Europe Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 52. Europe Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Anti-Migraine Drugs Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Anti-Migraine Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Anti-Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 61. Global Anti-Migraine Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 62. Global Anti-Migraine Drugs Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Anti-Migraine Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Anti-Migraine Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Anti-Migraine Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 66. Global Anti-Migraine Drugs Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Anti-Migraine Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Anti-Migraine Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 69. Eli Lilly Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 70. Eli Lilly Anti-Migraine Drugs Product Offered
Table 71. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 72. Eli Lilly Main Business
Table 73. Eli Lilly Latest Developments
Table 74. Abbott Laboratories Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Abbott Laboratories Anti-Migraine Drugs Product Offered
Table 76. Abbott Laboratories Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 77. Abbott Laboratories Main Business
Table 78. Abbott Laboratories Latest Developments
Table 79. Eisai Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Eisai Anti-Migraine Drugs Product Offered
Table 81. Eisai Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 82. Eisai Main Business
Table 83. Eisai Latest Developments
Table 84. Allergan Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Allergan Anti-Migraine Drugs Product Offered
Table 86. Allergan Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 87. Allergan Main Business
Table 88. Allergan Latest Developments
Table 89. Endo Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Endo Anti-Migraine Drugs Product Offered
Table 91. Endo Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 92. Endo Main Business
Table 93. Endo Latest Developments
Table 94. GlaxoSmithKline Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Anti-Migraine Drugs Product Offered
Table 96. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. Impax Laboratories Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Impax Laboratories Anti-Migraine Drugs Product Offered
Table 101. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 102. Impax Laboratories Main Business
Table 103. Impax Laboratories Latest Developments
Table 104. Pfizer Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Anti-Migraine Drugs Product Offered
Table 106. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. AstraZeneca Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. AstraZeneca Anti-Migraine Drugs Product Offered
Table 111. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 112. AstraZeneca Main Business
Table 113. AstraZeneca Latest Developments
Table 114. Bayer Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Bayer Anti-Migraine Drugs Product Offered
Table 116. Bayer Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 117. Bayer Main Business
Table 118. Bayer Latest Developments
Table 119. Johnson & Johnson Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Johnson & Johnson Anti-Migraine Drugs Product Offered
Table 121. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 122. Johnson & Johnson Main Business
Table 123. Johnson & Johnson Latest Developments
Table 124. Merck Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Merck Anti-Migraine Drugs Product Offered
Table 126. Merck Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 127. Merck Main Business
Table 128. Merck Latest Developments
Table 129. Teva Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Teva Anti-Migraine Drugs Product Offered
Table 131. Teva Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 132. Teva Main Business
Table 133. Teva Latest Developments
Table 134. Amgen Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Amgen Anti-Migraine Drugs Product Offered
Table 136. Amgen Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 137. Amgen Main Business
Table 138. Amgen Latest Developments
List of Figures
Figure 1. Picture of Anti-Migraine Drugs
Figure 2. Anti-Migraine Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Migraine Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Anti-Migraine Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Anti-Migraine Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Triptans
Figure 10. Product Picture of Ergots
Figure 11. Product Picture of Others
Figure 12. Global Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 13. Global Anti-Migraine Drugs Revenue Market Share by Type (2016-2021)
Figure 14. Anti-Migraine Drugs Consumed in Women
Figure 15. Global Anti-Migraine Drugs Market: Women (2016-2021) & (K Units)
Figure 16. Anti-Migraine Drugs Consumed in Men
Figure 17. Global Anti-Migraine Drugs Market: Men (2016-2021) & (K Units)
Figure 18. Global Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Figure 19. Global Anti-Migraine Drugs Revenue Market Share by Application in 2020
Figure 20. Global Anti-Migraine Drugs Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Anti-Migraine Drugs Revenue Market Share by Company in 2020
Figure 22. Global Anti-Migraine Drugs Sales Market Share by Regions (2016-2021)
Figure 23. Global Anti-Migraine Drugs Revenue Market Share by Region in 2020
Figure 24. Americas Anti-Migraine Drugs Sales 2016-2021 (K Units)
Figure 25. Americas Anti-Migraine Drugs Revenue 2016-2021 ($ Millions)
Figure 26. APAC Anti-Migraine Drugs Sales 2016-2021 (K Units)
Figure 27. APAC Anti-Migraine Drugs Revenue 2016-2021 ($ Millions)
Figure 28. Europe Anti-Migraine Drugs Sales 2016-2021 (K Units)
Figure 29. Europe Anti-Migraine Drugs Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Anti-Migraine Drugs Sales 2016-2021 (K Units)
Figure 31. Middle East & Africa Anti-Migraine Drugs Revenue 2016-2021 ($ Millions)
Figure 32. Americas Anti-Migraine Drugs Sales Market Share by Country in 2020
Figure 33. Americas Anti-Migraine Drugs Revenue Market Share by Country in 2020
Figure 34. Americas Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 35. Americas Anti-Migraine Drugs Sales Market Share by Application in 2020
Figure 36. United States Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Anti-Migraine Drugs Sales Market Share by Region in 2020
Figure 41. APAC Anti-Migraine Drugs Revenue Market Share by Regions in 2020
Figure 42. APAC Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 43. APAC Anti-Migraine Drugs Sales Market Share by Application in 2020
Figure 44. China Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Anti-Migraine Drugs Sales Market Share by Country in 2020
Figure 51. Europe Anti-Migraine Drugs Revenue Market Share by Country in 2020
Figure 52. Europe Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 53. Europe Anti-Migraine Drugs Sales Market Share by Application in 2020
Figure 54. Germany Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Anti-Migraine Drugs Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Application in 2020
Figure 63. Egypt Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Anti-Migraine Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


★調査レポート[世界の抗片頭痛薬市場予測 2021年-2026年] (コード：LPI21MY9422)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗片頭痛薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗肥満薬市場予測 2021年-2026年
    LPI21MY9410 / LP Information / 2021年5月 / LPインフォメーション社の「抗肥満薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口薬、ダイエットパッチ、その他など、用途別には、男性、女性などにセグメント区分してまとめました。抗肥満薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗肥満薬の世界市場概要（サマリー） ・抗肥満薬の企業別販売量・売上 ・抗肥満薬の企業別市場シェア ・抗肥満薬の世界市場規模 2016年-2021年：種類別（経口薬、ダイエットパッチ、その他） ・抗肥満薬の世界市場規模 2016年-2021年：用途別（男性、女性） ・抗肥満薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗肥満薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Obesity Drugs will have significant change from previous year. By the most conservative estimates of global Anti Obesity Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Obesity Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Obesity Drugs market by product type,...
  • 世界の降圧薬市場予測 2021年-2026年
    LPI21MY9420 / LP Information / 2021年5月 / LPインフォメーション社の「降圧薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。降圧薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・降圧薬の世界市場概要（サマリー） ・降圧薬の企業別販売量・売上 ・降圧薬の企業別市場シェア ・降圧薬の世界市場規模 2016年-2021年：種類別（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬） ・降圧薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局） ・降圧薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・降圧薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-Hypertensive Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Hypertensive Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 39390 million in 2019. Over the next five years the Anti-Hypertensive Drugs market will register a 1.7% CAGR in terms of revenue, the global market size will reach US$ 42110 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Hypertensive Drugs market by product type, application, key manufacturers and...
  • 世界の抗消化性潰瘍薬市場予測 2021年-2026年
    LPI21MY9411 / LP Information / 2021年5月 / LPインフォメーション社の「抗消化性潰瘍薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬など、用途別には、胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）などにセグメント区分してまとめました。抗消化性潰瘍薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗消化性潰瘍薬の世界市場概要（サマリー） ・抗消化性潰瘍薬の企業別販売量・売上 ・抗消化性潰瘍薬の企業別市場シェア ・抗消化性潰瘍薬の世界市場規模 2016年-2021年：種類別（プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬） ・抗消化性潰瘍薬の世界市場規模 2016年-2021年：用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・抗消化性潰瘍薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗消化性潰瘍薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Peptic Ulcer Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Peptic Ulcer Drugs...
  • 世界の免疫抑制薬市場予測 2021年-2026年
    LPI21MY9646 / LP Information / 2021年5月 / LPインフォメーション社の「免疫抑制薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、カルシニューリン阻害剤、MTOR阻害剤、抗増殖剤、ステロイド、抗体など、用途別には、腎臓、骨髄、その他などにセグメント区分してまとめました。免疫抑制薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・免疫抑制薬の世界市場概要（サマリー） ・免疫抑制薬の企業別販売量・売上 ・免疫抑制薬の企業別市場シェア ・免疫抑制薬の世界市場規模 2016年-2021年：種類別（カルシニューリン阻害剤、MTOR阻害剤、抗増殖剤、ステロイド、抗体） ・免疫抑制薬の世界市場規模 2016年-2021年：用途別（腎臓、骨髄、その他） ・免疫抑制薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・免疫抑制薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Immunosuppressant Drugs will have significant change from previous year. By the most conservative estimates of global Immunosuppressant Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Immunosuppressant Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Immunosuppressant Drugs market by product type, application, key manufacturers and...
  • 世界の点眼薬市場予測 2021年-2026年
    LPI21MY9609 / LP Information / 2021年5月 / LPインフォメーション社の「点眼薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬など、用途別には、緑内障、ドライアイ症候群、網膜疾患、その他などにセグメント区分してまとめました。点眼薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・点眼薬の世界市場概要（サマリー） ・点眼薬の企業別販売量・売上 ・点眼薬の企業別市場シェア ・点眼薬の世界市場規模 2016年-2021年：種類別（網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬） ・点眼薬の世界市場規模 2016年-2021年：用途別（緑内障、ドライアイ症候群、網膜疾患、その他） ・点眼薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・点眼薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Ophthalmol Drugs will have significant change from previous year. By the most conservative estimates of global Ophthalmol Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Ophthalmol Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmol Drugs market by product type, application, key manufacturers and...
  • 世界の獣医痛み管理薬市場予測 2021年-2026年
    LPI21MY9684 / LP Information / 2021年5月 / LPインフォメーション社の「獣医痛み管理薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、オピオイド、α2-アドレナリン作動薬、局所麻酔薬、非ステロイド性抗炎症薬（NSID）、鎮静剤、コルチコステロイド、その他など、用途別には、獣医病院、獣医クリニック、小売用などにセグメント区分してまとめました。獣医痛み管理薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・獣医痛み管理薬の世界市場概要（サマリー） ・獣医痛み管理薬の企業別販売量・売上 ・獣医痛み管理薬の企業別市場シェア ・獣医痛み管理薬の世界市場規模 2016年-2021年：種類別（オピオイド、α2-アドレナリン作動薬、局所麻酔薬、非ステロイド性抗炎症薬（NSID）、鎮静剤、コルチコステロイド、その他） ・獣医痛み管理薬の世界市場規模 2016年-2021年：用途別（獣医病院、獣医クリニック、小売用） ・獣医痛み管理薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・獣医痛み管理薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Veterinary Pain Management Drugs will have significant change from previous year. By the most conservative estimates of global Veterinary Pain Management Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Veterinary Pain Management Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Pain Management Drugs...
  • 世界の抗糖尿病薬市場予測 2021年-2026年
    LPI21MY9415 / LP Information / 2021年5月 / LPインフォメーション社の「抗糖尿病薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口薬、注射薬など、用途別には、1型糖尿病、2型糖尿病、妊娠糖尿病、その他などにセグメント区分してまとめました。抗糖尿病薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗糖尿病薬の世界市場概要（サマリー） ・抗糖尿病薬の企業別販売量・売上 ・抗糖尿病薬の企業別市場シェア ・抗糖尿病薬の世界市場規模 2016年-2021年：種類別（経口薬、注射薬） ・抗糖尿病薬の世界市場規模 2016年-2021年：用途別（1型糖尿病、2型糖尿病、妊娠糖尿病、その他） ・抗糖尿病薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗糖尿病薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antidiabetic Drugs will have significant change from previous year. By the most conservative estimates of global Antidiabetic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Antidiabetic Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antidiabetic Drugs market by product type, application, key manufacturers and...
  • 世界のオキシコドン塩酸塩治療薬市場予測 2021年-2026年
    LPI21MY9614 / LP Information / 2021年5月 / LPインフォメーション社の「オキシコドン塩酸塩治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、錠剤、経口液剤、経口カプセル、静脈内輸液など、用途別には、病院、診療所、その他などにセグメント区分してまとめました。オキシコドン塩酸塩治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・オキシコドン塩酸塩治療薬の世界市場概要（サマリー） ・オキシコドン塩酸塩治療薬の企業別販売量・売上 ・オキシコドン塩酸塩治療薬の企業別市場シェア ・オキシコドン塩酸塩治療薬の世界市場規模 2016年-2021年：種類別（錠剤、経口液剤、経口カプセル、静脈内輸液） ・オキシコドン塩酸塩治療薬の世界市場規模 2016年-2021年：用途別（病院、診療所、その他） ・オキシコドン塩酸塩治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・オキシコドン塩酸塩治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Oxycodone Hydrochloride Drugs will have significant change from previous year. By the most conservative estimates of global Oxycodone Hydrochloride Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Oxycodone Hydrochloride Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Oxycodone Hydrochloride Drugs market by product type,...
  • 世界の抗感染API市場予測 2021年-2026年
    LPI21MY0707 / LP Information / 2021年5月 / LPインフォメーション社の「抗感染APIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、β-ラクタム薬、マクロライド系抗生物質、カルバペネム系抗生物質、キノロン系抗生物質など、用途別には、全身用抗菌薬、全身用抗ウイルス薬、全身用抗原、細菌、免疫血清・免疫グロブリン、抗酸菌薬、ワクチン、その他などにセグメント区分してまとめました。抗感染APIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗感染APIの世界市場概要（サマリー） ・抗感染APIの企業別販売量・売上 ・抗感染APIの企業別市場シェア ・抗感染APIの世界市場規模 2016年-2021年：種類別（β-ラクタム薬、マクロライド系抗生物質、カルバペネム系抗生物質、キノロン系抗生物質） ・抗感染APIの世界市場規模 2016年-2021年：用途別（全身用抗菌薬、全身用抗ウイルス薬、全身用抗原、細菌、免疫血清・免疫グロブリン、抗酸菌薬、ワクチン、その他） ・抗感染APIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗感染APIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Anti-infective API will have significant change from previous year. By the most conservative estimates of global Anti-infective API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Anti-infective API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-infective API market by product type, application, key manufacturers and...
  • 世界のジョサマイシン薬市場予測 2021年-2026年
    LPI21MY9651 / LP Information / 2021年5月 / LPインフォメーション社の「ジョサマイシン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒など、用途別には、病院薬局、小売ドラッグストアなどにセグメント区分してまとめました。ジョサマイシン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ジョサマイシン薬の世界市場概要（サマリー） ・ジョサマイシン薬の企業別販売量・売上 ・ジョサマイシン薬の企業別市場シェア ・ジョサマイシン薬の世界市場規模 2016年-2021年：種類別（ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒） ・ジョサマイシン薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売ドラッグストア） ・ジョサマイシン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ジョサマイシン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Josamycin Drugs will have significant change from previous year. By the most conservative estimates of global Josamycin Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Josamycin Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Josamycin Drugs market by product type, application, key manufacturers and...

    • ◆H&Iグローバルリサーチのお客様（例）◆